Stock analysts at JP Morgan Cazenove increased their price target on shares of CareFusion Corp. (NYSE: CFN) from $35.00 to $41.00 in a report issued on Friday, AnalystRatings.Net reports. The firm currently has an “overweight” rating on the stock. JP Morgan Cazenove’s target price points to a potential upside of 6.33% from the company’s current price.
A number of other firms have also recently commented on CFN. Analysts at BMO Capital Markets reiterated an “outperform” rating on shares of CareFusion Corp. in a research note to investors on Monday. They now have a $41.00 price target on the stock, up previously from $38.00. Separately, analysts at B. Riley reiterated a “neutral” rating on shares of CareFusion Corp. in a research note to investors on Thursday, June 13th. They now have a $33.00 price target on the stock. Finally, analysts at Barclays Capital reiterated a “hold” rating on shares of CareFusion Corp. in a research note to investors on Thursday, June 6th. They now have a $35.00 price target on the stock.
Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. CareFusion Corp. presently has a consensus rating of “Buy” and an average price target of $35.75.
CareFusion Corp. (NYSE: CFN) traded up 0.10% on Friday, hitting $38.56. CareFusion Corp. has a 52-week low of $23.93 and a 52-week high of $38.64. The stock’s 50-day moving average is currently $37.09. The company has a market cap of $8.476 billion and a price-to-earnings ratio of 23.22.
CareFusion Corp. (NYSE: CFN) last issued its quarterly earnings data on Thursday, May 9th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.06. The company had revenue of $901.00 million for the quarter, compared to the consensus estimate of $909.16 million. CareFusion Corp.’s revenue was down 2.0% compared to the same quarter last year. CareFusion Corp. has set its FY13 guidance at $2.11-2.21 EPS. Analysts expect that CareFusion Corp. will post $2.13 EPS for the current fiscal year.
CareFusion Corporation (NYSE: CFN) is a global medical technology company.